Purple Biotech Ltd
NASDAQ:PPBT

  • LAST PRICE
    1.1500
  • TODAY'S CHANGE (%)
    0.1100 (10.5769%)
  • Bid / Lots
    1.0700/ 10
  • Ask / Lots
    1.1700/ 3
  • Open / Previous Close
    1.0800 / 1.0400
  • Day Range
    1.0300
    1.1800
  • 52 Week Range
    1.0100
    2.3700
  • Volume
    85,220

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
PPBT
Purple Biotech Ltd
23.5M
-0.4x
---
AXLA
Axcella Health Inc
23.4M
-0.4x
---
SNSE
Sensei Biotherapeutics Inc
23.4M
-0.5x
---
INDP
Indaptus Therapeutics Inc
23.4M
-1.5x
---
GNPX
Genprex Inc
23.7M
-0.6x
---
MYMD
MyMD Pharmaceuticals Inc
22.9M
-1.5x
---
As of 2023-09-28

Company Information

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Contact Information

Headquarters
4 Oppenheimer St., Science ParkREHOVOT, Israel 7670104
Phone
---
Fax
---

Executives

Chairman of the Board
Eric Rowinsky
Chief Executive Officer & Director
Itzhak Israel
Deputy Chief Executive Officer, Chief Financial Officer
Gil Efron
Vice President - Business Development
Gil Ben-Menachem
General Counsel, Secretary
Avraham Ben-Tzvi

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$23.5M
Revenue (TTM)
$0.00
Shares Outstanding
21.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.77
EPS
$-3.29
Book Value
$2.54
P/E Ratio
-0.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.